LeonaBio (LONA) Operating Income (2019 - 2026)

LeonaBio (LONA) has 8 years of Operating Income data on file, last reported at -$17.2 million in Q1 2026.

• Operating Income for Q1 2026 came in at -$17.2 million, down 80.52% year-over-year; the trailing twelve-month figure through Mar 2026 was -$109.9 million (down 32.86% YoY), and the FY2025 annual result was -$102.3 million, down 1.35% from the prior year.
• Operating Income grew to -$17.2 million in Q1 2026 per LONA's latest filing, from -$78.6 million in the prior quarter.
• Over five years, Operating Income peaked at -$6.9 million in Q3 2025 and troughed at -$78.6 million in Q4 2025.
• A 5-year average of -$26.5 million and a median of -$27.7 million in 2024 frame the typical range for Operating Income.
• On a YoY basis, Operating Income climbed as much as 76.79% in 2025 and fell as far as 404.72% in 2025.
• A 5-year view of Operating Income shows it stood at -$32.9 million in 2022, then grew by 11.88% to -$29.0 million in 2023, then soared by 46.35% to -$15.6 million in 2024, then slumped by 404.72% to -$78.6 million in 2025, then soared by 78.09% to -$17.2 million in 2026.
• Business Quant data shows LONA's Operating Income at -$17.2 million in Q1 2026, -$78.6 million in Q4 2025, and -$6.9 million in Q3 2025.